Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 1, 2023 -- Mechanical thrombectomy (MT) is safe and effective in real-world, high-risk patients with pulmonary embolism (PE), according to a study published online Oct. 31 in the Journal of the Society for Cardiovascular Angiography & Interventions.
James M. Horowitz, M.D., from the NYU Grossman School of Medicine in New York City, and colleagues assessed the safety and effectiveness of MT for high-risk PE. The analysis included 63 real-world, high-risk patients identified through the multicenter FlowTriever All-comer Registry for Patient Safety and Hemodynamics study.
The researchers found that 47.6 percent of patients showed a systolic blood pressure <90 mm Hg, 46.0 percent required vasopressors, and 6.3 percent experienced cardiac arrest. At baseline, 72.6 percent of patients were tachycardic, 54.5 percent showed elevated lactate levels of ≥2.5 mM, and 42.9 percent showed a depressed cardiac index of <2 L/min/m2. Heart rate improved immediately after MT to 93.5 beats per minute. Twenty-five patients (42.4 percent) did not require an overnight stay in the intensive care unit. No mortalities or major adverse events occurred through 48 hours, and at 30-day follow-up, no mortalities occurred.
"Our findings highlight the effectiveness of mechanical thrombectomy as a first-line treatment for high-risk pulmonary embolism," Horowitz said in a statement. "By removing blood clots from the lungs, this procedure can rapidly restore blood flow and prevent fatal complications."
Several authors disclosed ties to the medical technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-02 00:34
Read more
- Racial, Ethnic Differences Seen in Cleft Lip Surgery Repair
- Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
- When Complications Strike After Heart Surgery, Women More Likely to Die Than Men
- COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
- Orexo initiates new study of OX640 in participants with allergic rhiniti
- Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions